Evidence map›Paper›PMID 38448849›Full record

ArticleBMC public health2024

Development and validation of a deep learning model for predicting postoperative survival of patients with gastric cancer.

Mengjie Wu, Xiaofan Yang, Yuxi Liu, Feng Han, Xi Li, Jufeng Wang, Dandan Guo, Xiance Tang, Lu Lin, Changpeng Liu

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mengjie WuDepartment of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, China.
Xiaofan YangDepartment of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, China.
Yuxi LiuDepartment of Medical Records, Office for DRGs (Diagnosis Related Groups), Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Rd, PO Box 0061, Zhengzhou, Henan Province, 450008, China.
Feng HanDepartment of Medical Records, Office for DRGs (Diagnosis Related Groups), Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Rd, PO Box 0061, Zhengzhou, Henan Province, 450008, China.
Xi LiDepartment of Medical Records, Office for DRGs (Diagnosis Related Groups), Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Rd, PO Box 0061, Zhengzhou, Henan Province, 450008, China.
Jufeng WangDepartment of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008, China.
Dandan GuoDepartment of Radiology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiance TangDepartment of Medical Records, Office for DRGs (Diagnosis Related Groups), Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Rd, PO Box 0061, Zhengzhou, Henan Province, 450008, China.
Lu LinTranslational Medicine Research Center, People's Hospital of Henan University of Chinese Medicine, Zhengzhou People's Hospital, Zhengzhou, Henan, 450003, China.
Changpeng LiuDepartment of Medical Records, Office for DRGs (Diagnosis Related Groups), Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Rd, PO Box 0061, Zhengzhou, Henan Province, 450008, China. zlyylcp4508@zzu.edu.cn.
Zhengzhou University · CNThird Affiliated Hospital of Zhengzhou University · CNZhengzhou People's Hospital · CN

Funding

Programs for Science and Technology Development of Henan Province 212102310198
6 · The paper itself

Abstract

backgroundDeep learning (DL), a specialized form of machine learning (ML), is valuable for forecasting survival in various diseases. Its clinical applicability in real-world patients with gastric cancer (GC) has yet to be extensively validated.

methodsA combined cohort of 11,414 GC patients from the Surveillance, Epidemiology and End Results (SEER) database and 2,846 patients from a Chinese dataset were utilized. The internal validation of different algorithms, including DL model, traditional ML models, and American Joint Committee on Cancer (AJCC) stage model, was conducted by training and testing sets on the SEER database, followed by external validation on the Chinese dataset. The performance of the algorithms was assessed using the area under the receiver operating characteristic curve, decision curve, and calibration curve.

resultsDL model demonstrated superior performance in terms of the area under the curve (AUC) at 1, 3, and, 5 years post-surgery across both datasets, surpassing other ML models and AJCC stage model, with AUCs of 0.77, 0.80, and 0.82 in the SEER dataset and 0.77, 0.76, and 0.75 in the Chinese dataset, respectively. Furthermore, decision curve analysis revealed that the DL model yielded greater net gains at 3 years than other ML models and AJCC stage model, and calibration plots at 3 years indicated a favorable level of consistency between the ML and actual observations during external validation.

conclusionsDL-based model was established to accurately predict the survival rate of postoperative patients with GC.

Indexed as

Deep LearningStomach NeoplasmsAlgorithmsArea Under CurveAsian PeopleHumansNorth American PeopleDeep learningGastric cancerMachine learningPredictive modelSurvival rate

Identifiers

PMID38448849
PMCPMC10916254
OpenAlexW4392517299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.